Ad5/35E1aPSESE4: A novel approach to marking circulating prostate tumor cells with a replication competent adenovirus controlled by PSA/PSMA transcription regulatory elements

Cancer Letters

Volumn 372, Issue 1, 2016, Pages 57-64

  Hwang, Ji Eun ^a   Joung, Jae Young ^a   Shin, Seung Phil ^a   Choi, Moon Kyung ^a   Kim, Jeong Eun ^a   Kim, Yon Hui ^a   Park, Weon Seo ^a   Lee, Sang Jin ^a   Lee, Kang Hyun ^a  

^a National Cancer Center   (South Korea)

Author keywords

Adenovirus; Circulating tumor cell; Prostate cancer

Indexed keywords

ADENOVIRIDAE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER STAGING; CIRCULATING TUMOR CELL; COCULTURE; COFILIN1 GENE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EX VIVO STUDY; FCER1G GENE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MMP9 GENE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA SEQUENCE; TRANSCRIPTION REGULATION; VIRUS REPLICATION; ADULT; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CASE CONTROL STUDY; DISEASE COURSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; PREDICTIVE VALUE; PROSTATIC NEOPLASMS; REGULATORY SEQUENCE; REPORTER GENE; REPRODUCIBILITY; TIME FACTOR; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR EMBOLISM; VALIDATION STUDY; VIROLOGY; YOUNG ADULT;

ANTINEOPLASTIC AGENT; DOCETAXEL; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; GREEN FLUORESCENT PROTEIN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; MEMBRANE ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TAXOID;

ADENOVIRIDAE; ADULT; ANIMALS; ANTIGENS, SURFACE; ANTINEOPLASTIC AGENTS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENES, REPORTER; GLUTAMATE CARBOXYPEPTIDASE II; GREEN FLUORESCENT PROTEINS; HUMANS; KALLIKREINS; MALE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; REPRODUCIBILITY OF RESULTS; TAXOIDS; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VIRUS REPLICATION; YOUNG ADULT;

EID: 84958156595     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.12.018     Document Type: Article

References (25)

1. I.A.f.R.o. Cancer, W.H. Organization, GLOBOCAN: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012, IARC2014.
2. Lim J., Bhoo-Pathy N., Sothilingam S., Malek R., Sundram M., Bahadzor B.H., et al. Ethnicity is an independent determinant of age-specific PSA level: findings from a multiethnic Asian setting. PLoS ONE 2014, 9(8):e104917.
3. Barry M.J. Prostate-specific-antigen testing for early diagnosis of prostate cancer. NEJM 2001, 344:1373-1377.
4. Gupta G.P., Massagué J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
5. Zhang L., Riethdorf S., Wu G., Wang T., Yang K., Peng G., et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin. Cancer Res 2012, 18:5701-5710.
6. Alix-Panabieres C., Pantel K. Challenges in circulating tumour cell research. Nat. Rev. Cancer 2014, 14:623-631.
7. Yokobori T., Iinuma H., Shimamura T., Imoto S., Sugimachi K., Ishii H., et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res 2013, 73:2059-2069.
8. Danila D.C., Heller G., Gignac G.A., Gonzalez-Espinoza R., Anand A., Tanaka E., et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin. Cancer Res 2007, 13:7053-7058.
9. Harrison S.C. Looking inside adenovirus. Science 2010, 329:1026-1027.
10. Melquist J.J., Kacka M., Li Y., Malaeb B.S., Elmore J., Baseman A.G., et al. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model. Urol. Oncol 2006, 24:362-371.
11. Shirakawa T., Hamada K., Zhang Z., Okada H., Tagawa M., Kamidono S., et al. A cox-promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells. Clin. Cancer Res 2004, 10:4342-4348.
12. Kojima T., Hashimoto Y., Watanabe Y., Kagawa S., Uno F., Kuroda S., et al. A simple biological imaging system for detecting viable human circulating tumor cells. J. Clin. Invest 2009, 119:3172-3181.
13. Wu P., Sokoll L.J., Kudrolli T.A., Chowdhury W.H., Ma R., Liu M.M., et al. A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector. Prostate 2014, 74:1286-1296.
14. Li X., Zhang Y.P., Kim H.S., Bae K.H., Stantz K.M., Lee S.J., et al. Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer. Cancer Res 2005, 65:1941-1951.
15. Li X., Liu Y.H., Lee S.J., Gardner T.A., Jeng M.H., Kao C. Prostate-restricted replicative adenovirus expressing human endostatin-angiostatin fusion gene exhibiting dramatic antitumor efficacy. Clin. Cancer Res 2008, 14:291-299.
16. Han M., Partin A.W., Zahurak M., Piantadosi S., Epstein J.I., Walsh P.C. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J. Urol 2003, 169:517-523.
17. Joung J.Y., Cho K.S., Chung H.S., Cho I.C., Kim J.E., Seo H.K., et al. Prostate specific membrane antigen mRNA in blood as a potential predictor of biochemical recurrence after radical prostatectomy. J. Korean Med. Sci 2010, 25:1291-1295.
18. Joung J.Y., Cho K.S., Kim J.E., Seo H.K., Chung J., Park W.S., et al. Prostate stem cell antigen mRNA in peripheral blood as a potential predictor of biochemical recurrence in high-risk prostate cancer. J. Surg. Oncol 2010, 101:145-148.
19. Pantel K., Alix-Panabières C. Real-time liquid biopsy in cancer patients: fact or fiction?. Cancer Res 2013, 73:6384-6388.
20. Witzig T.E., Bossy B., Kimlinger T., Roche P.C., Ingle J.N., Grant C., et al. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin. Cancer Res 2002, 8:1085-1091.
21. Iinuma H., Okinaga K., Adachi M., Suda K., Sekine T., Sakagawa K., et al. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer. Int. J. Cancer 2000, 89:337-344.
22. Kong S.Y., Park J.W., Kim J.O., Lee N.O., Lee J.A., Park K.W., et al. Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma. J. Cancer Res. Clin. Oncol 2009, 135:1091-1098.
23. Wang H.Y., Ahn S., Kim S., Park S., Jung D., Park S., et al. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay. Int. J. Clin. Oncol 2015, 20(5):878-890.
24. Petrylak D.P. Practical guide to the use of chemotherapy in castration resistant prostate cancer. Can. J. Urol 2014, 21:77-83.
25. Petrylak D.P., Tangen C.M., Hussain M.H., Lara P.N., Jones J.A., Taplin M.E., et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. NEJM 2004, 351:1513-1520.